Author:
Harbeck Nadia,Thomssen Christoph,Berger Ursula,Ulm Kurt,Kates Ronald E.,Höfler Heinz,Jänicke Fritz,Graeff Henner,Schmitt Manfred
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1–15, 71–85, 1992
2. McGuire W, Clark GM: Prognostic factors and treatment decisions in axillary node-negative breast cancer. N Engl J Med 326: 1756–1761, 1992
3. Clark G: Prognostic and predictive factors. In: Harris JR, Lippman ME, Morrow M, Hellmann S (eds). Diseases of the Breast. Lippincott-Raven, Philadelphia, 1996, pp 461–485
4. Duffy MJ, O'Grady P, Devaney D, O'Siorain L, Fennelly JJ, Lijnen HJ: Urokinase-plasminogen activator, a marker for aggressive breast cancers. Cancer 62: 531–533, 1988
5. Jänicke F, Schmitt M, Hafter R, Hollrieder A, Babic R, Ulm K, Gössner W, Graeff H: Urokinase-type plasminogen activator (uPA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 4: 69–78, 1990
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献